Mitoxantrone and ejection fraction decreased Patient Reports February 12, 2012

Mitoxantrone Side Effects Report #4805103-5
Mitoxantrone side effect was reported by a Physician from GERMANY on Sept 29, 2005. Male patient, 24 years of age, was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: cardiomyopathy , ejection fraction decreased, white blood cell count decreased. Mitoxantrone dosage: 12 MG/M2. Patient recovered.

Mitoxantrone Side Effects Report #5009799-7
Mitoxantrone side effect was reported by a Consumer or non-health professional from FRANCE on May 11, 2006. Female patient was diagnosed with multiple sclerosis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ejection fraction decreased, haemorrhage, neutropenia, respiratory distress, sepsis . Mitoxantrone dosage: 20 MG MONTHLY UNK. Patient recovered.

Mitoxantrone Side Effects Report #5427706-X
Mitoxantrone side effect was reported by a Consumer or non-health professional from GERMANY on Aug 15, 2007. Male patient, 58 years of age, was diagnosed with encephalitis  and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. Mitoxantrone dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.

Mitoxantrone Side Effects Report #5869859-5
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2008. Female patient, 36 years of age, was diagnosed with b-cell lymphoma stage iv, breast cancer metastatic and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, diffuse large b-cell lymphoma stage iv, ejection fraction decreased, fatigue, gait disturbance. Mitoxantrone dosage: unknown. During the same period patient was treated with PACLITAXEL, DOXORUBICIN, RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient recovered.


Mitoxantrone Side Effects Report #5041045-0
Mitoxantrone side effect was reported by a Pharmacist from UNITED STATES on June 30, 2006. Female patient was diagnosed with acute myeloid leukaemia and was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: ejection fraction decreased, heart rate increased, hypotension, pericardial effusion. Mitoxantrone dosage: 6 MG/M2 DAY EVERY 12 HOURS IV. Patient died on 05/20/2006.

Mitoxantrone Side Effects Report #5382147-9
Mitoxantrone side effect was reported by a Health Professional from GERMANY on June 19, 2007. Female patient was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. Mitoxantrone dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.

Mitoxantrone Side Effects Report #5388462-7
Mitoxantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on June 29, 2007. Female patient was treated with Mitoxantrone. After drug was administered, patient experienced the following side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia. Mitoxantrone dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.